As of Mar 27
| +0.67 / +2.41%|
The 3 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 34.00, with a high estimate of 35.00 and a low estimate of 30.00. The median estimate represents a +19.21% increase from the last price of 28.52.
The current consensus among 3 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.